Berenberg Bank upgraded shares of Inspire Medical Systems (NYSE:INSP) from a sell rating to a hold rating in a report issued on Wednesday morning, Briefing.com Automated Import reports. Berenberg Bank currently has $51.00 price objective on the stock, up from their previous price objective of $46.00.

Other equities analysts also recently issued research reports about the stock. ValuEngine downgraded shares of Inspire Medical Systems from a hold rating to a sell rating in a report on Thursday, October 31st. Zacks Investment Research downgraded shares of Inspire Medical Systems from a buy rating to a hold rating in a report on Wednesday, October 30th. Finally, Dougherty & Co set a $78.00 price objective on shares of Inspire Medical Systems and gave the stock a buy rating in a report on Friday, September 27th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus price target of $68.25.

Shares of INSP stock traded up $4.31 during mid-day trading on Wednesday, reaching $64.05. 405,533 shares of the company were exchanged, compared to its average volume of 306,413. Inspire Medical Systems has a fifty-two week low of $35.43 and a fifty-two week high of $71.71. The company has a debt-to-equity ratio of 0.16, a quick ratio of 20.05 and a current ratio of 20.46. The company has a market capitalization of $1.45 billion, a P/E ratio of -42.70 and a beta of 1.22. The business’s 50 day simple moving average is $58.89 and its 200 day simple moving average is $60.15.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings results on Tuesday, November 5th. The company reported ($0.34) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.43) by $0.09. Inspire Medical Systems had a negative net margin of 40.36% and a negative return on equity of 18.32%. The business had revenue of $20.86 million during the quarter, compared to the consensus estimate of $19.15 million. During the same quarter last year, the company earned ($0.22) earnings per share. The business’s quarterly revenue was up 59.8% compared to the same quarter last year. On average, analysts forecast that Inspire Medical Systems will post -1.55 EPS for the current year.

In other Inspire Medical Systems news, insider Randy Ban sold 10,000 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $61.62, for a total value of $616,200.00. Also, Director Mudit K. Jain sold 1,250 shares of the firm’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $68.89, for a total value of $86,112.50. The disclosure for this sale can be found here. In the last ninety days, insiders sold 191,790 shares of company stock valued at $12,433,812. 12.10% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of INSP. Marshall Wace North America L.P. bought a new stake in Inspire Medical Systems in the first quarter valued at $45,000. Commonwealth Equity Services LLC raised its stake in shares of Inspire Medical Systems by 37.7% during the second quarter. Commonwealth Equity Services LLC now owns 6,363 shares of the company’s stock valued at $385,000 after purchasing an additional 1,743 shares in the last quarter. First Quadrant L P CA bought a new stake in shares of Inspire Medical Systems during the second quarter valued at about $118,000. Strs Ohio raised its stake in shares of Inspire Medical Systems by 8.7% during the second quarter. Strs Ohio now owns 2,500 shares of the company’s stock valued at $151,000 after purchasing an additional 200 shares in the last quarter. Finally, Advisor Group Inc. raised its stake in shares of Inspire Medical Systems by 11.4% during the second quarter. Advisor Group Inc. now owns 9,697 shares of the company’s stock valued at $587,000 after purchasing an additional 996 shares in the last quarter. Institutional investors own 83.05% of the company’s stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Featured Story: What does it mean to hold a stock in street name?

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.